Single-dose Pharmacokinetics of Pociredir in Participants With Sickle Cell Disease

NCT07431398 · clinicaltrials.gov ↗

PHASE1

Phase

RECRUITING

Status

24

Enrollment

INDUSTRY

Sponsor class

Conditions

Sickle Cell Disease

Interventions

DRUG: Pociredir

Sponsor

Fulcrum Therapeutics